Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology Week Liechtenstein.
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
GlobeNewswire, Inc.
·
June 20, 2025
VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDP Approval based on ADHERE clinical trial, the largest study of CIDP patients to date First...
Dental Implants Market worth US$18.79 billion by 2030 with 8.4% CAGR | MarketsandMarkets™.
GlobeNewswire, Inc.
·
June 19, 2025
Delray Beach, FL, June 19, 2025 (GLOBE NEWSWIRE) -- The global dental implants market, valued at US$11.61 billion in 2024, stood at US$12.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in...
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
GlobeNewswire, Inc.
·
April 28, 2025
VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a healthcare professional PITTSBURGH, April 28,...
4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion
GlobeNewswire, Inc.
·
March 17, 2025
Press Release 4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will receive USD 400 million upfront, with the potential for additional near-term and long-term milestone payments...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio...
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
GlobeNewswire, Inc.
·
February 28, 2025
PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA’s) announcement that its Committee for Medicinal...
OSCE workshop fosters regional dialogue on climate change, human mobility, and security in South-Eastern Europe
Organization for Security and Co-operation in Europe
·
June 17, 2025
On 3 June, the Office of the Co-ordinator of OSCE Economic and Environmental Activities (OCEEA) hosted a regional workshop in Sarajevo, Bosnia and Herzegovina, bringing together over 50 experts, officials, civil society representatives, and...
Crypto Exchange LCX Files Pre-Application For MiCA License in Liechtenstein
GlobeNewswire, Inc.
·
December 24, 2024
Vaduz, Liechtenstein, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LCX, the Liechtenstein Cryptoassets Exchange, has officially filed a pre-application for the Pan-European MiCA (Markets in Crypto Assets Regulation) license under Liechtenstein’s Financial...
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire, Inc.
·
June 6, 2025
Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older who are able to walk The...
ISC’s Technology Solutions Segment Wins Liechtenstein Contract to Deliver a Digital Commercial Registry System
GlobeNewswire, Inc.
·
November 28, 2024
ISC wins contract with the Principality of Liechtenstein. Total contract valued at CHF$6.2 million (CA$10.0 million) over 5 years. Along with implementation, support and maintenance are included. Demonstrates ISC’s continued growth and expansion...
Introducing Obyte City: A Community Space to Find Neighbors and Earn Rewards
EIN Presswire
·
June 3, 2025
Obyte City is a new community space for Obyte to strengthen connections between community members TRIESEN, LIECHTENSTEIN, June 3, 2025 /EINPresswire.com/ -- Obyte proudly unveils Obyte City, a cypherpunk-inspired digital space designed to...
Increasing Oral Healthcare Awareness to Propel Dental Equipment Market Growth at USD 10.90 Billion by 2031 |SkyQuest Technology
GlobeNewswire, Inc.
·
October 18, 2024
Westford, USA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Dental Equipment Market size was valued at USD 6.79 billion in 2023 to USD 10.90 billion by 2031, growing at a CAGR of 6.10% during the forecast period (2024-2031). The tools that are utilized for...
Dental Consumables Market to Reach USD 53.27 Billion by 2031, Growing at 7.8% CAGR | SkyQuest Technology
GlobeNewswire, Inc.
·
September 18, 2024
Westford, USA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Dental Consumables Market will attain the value of USD 53.27 Billion by 2031, with a CAGR of 7.8% during the forecast period (2024-2031). Increased incidence of dental...
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
GlobeNewswire, Inc.
·
September 4, 2024
PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for therapies and treatments. A report from Transparency...
Ligand Reports First Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
May 8, 2025
First quarter performance driven by strong portfolio royalty revenue growth of 44% Strengthened commercial portfolio and pipeline through strategic transactions with Channel Therapeutics and Castle Creek Biosciences Reiterating 2025 financial...
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
GlobeNewswire, Inc.
·
April 16, 2025
Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today...
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GlobeNewswire, Inc.
·
April 28, 2025
VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDP First novel mechanism of action for CIDP treatment in more than 30 years CHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial European Commission...
OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas
GlobeNewswire, Inc.
·
April 8, 2025
Geneva, Switzerland, April 08, 2025 (GLOBE NEWSWIRE) -- The Financial Market Authority (FMA) in Liechtenstein has approved the security prospectus for OilXCoin for offering in key EEA jurisdictions and establishing its presence in the Real-World...
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
GlobeNewswire, Inc.
·
April 15, 2025
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*)...